Unknown

Dataset Information

0

Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.


ABSTRACT: Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is an immune-mediated disorder that occurs with IgG antibodies against the GluN1 subunit of NMDAR. Some patients develop reversible diffuse cerebral atrophy (DCA), but the long-term clinical significance of progressive brain and cerebellar atrophy is unknown.To report the long-term clinical implications of DCA and cerebellar atrophy in anti-NMDAR encephalitis.A retrospective observational study and long-term imaging investigation was conducted in the Department of Neurology at Kitasato University. Fifteen patients with anti-NMDAR encephalitis admitted to Kitasato University Hospital between January 1, 1999, and December 31, 2014, were included; data analysis was conducted between July 15, 2015, and January 18, 2016.Neurologic examination, immunotherapy, and magnetic resonance imaging (MRI) studies were performed.Long-term MRI changes in association with disease severity, serious complications (eg, pulmonary embolism, septic shock, and rhabdomyolysis), treatment, and outcome.The clinical outcome of 15 patients (median age, 21 years, [range, 14-46 years]; 10 [67%] female) was evaluated after a median follow-up of 68 months (range, 10-179 months). Thirteen patients (87%) received first-line immunotherapy (intravenous high-dose methylprednisolone, intravenous immunoglobulin, and plasma exchange alone or combined), and 4 individuals (27%) also received cyclophosphamide; 2 patients (13%) did not receive immunotherapy. In 5 patients (33%), ovarian teratoma was found and removed. Serious complications developed in 4 patients (27%). Follow-up MRI revealed DCA in 5 patients (33%) that, in 2 individuals (13%), was associated with progressive cerebellar atrophy. Long-term outcome was good in 13 patients (87%) and poor in the other 2 individuals (13%). Although cerebellar atrophy was associated with poor long-term outcome (2 of 2 vs 0 of 13 patients; P?=?.01), other features, such as DCA without cerebellar atrophy, serious complications, ventilatory support, or prolonged hospitalization, were not associated with a poor outcome. Five patients with DCA had longer hospitalizations (11.1 vs 2.4 months; P?=?.002), required ventilatory support more frequently (5 of 5 vs 4 of 10 patients; P?=?.04), and developed more serious complications (4 of 5 vs 0 of 10 patients; P?=?.004) compared with those without DCA. Although DCA was reversible, cerebellar atrophy was irreversible.In anti-NMDAR encephalitis, DCA can be reversible and does not imply a poor clinical outcome. In contrast, cerebellar atrophy was irreversible and associated with a poor outcome. This observation deserves further study to confirm progressive cerebellar atrophy as a prognostic marker of poor outcome.

SUBMITTER: Iizuka T 

PROVIDER: S-EPMC5018902 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.

Iizuka Takahiro T   Kaneko Juntaro J   Tominaga Naomi N   Someko Hidehiro H   Nakamura Masaaki M   Ishima Daisuke D   Kitamura Eiji E   Masuda Ray R   Oguni Eiichi E   Yanagisawa Toshiyuki T   Kanazawa Naomi N   Dalmau Josep J   Nishiyama Kazutoshi K  

JAMA neurology 20160601 6


<h4>Importance</h4>Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is an immune-mediated disorder that occurs with IgG antibodies against the GluN1 subunit of NMDAR. Some patients develop reversible diffuse cerebral atrophy (DCA), but the long-term clinical significance of progressive brain and cerebellar atrophy is unknown.<h4>Objective</h4>To report the long-term clinical implications of DCA and cerebellar atrophy in anti-NMDAR encephalitis.<h4>Design, setting, and participants</h4>A r  ...[more]

Similar Datasets

| S-EPMC5413277 | biostudies-literature
| S-EPMC2586938 | biostudies-literature
| S-EPMC7059175 | biostudies-literature
| S-EPMC2430743 | biostudies-literature
| S-EPMC2826225 | biostudies-literature
| S-EPMC6684284 | biostudies-literature
| S-EPMC6764498 | biostudies-literature
| S-EPMC6410529 | biostudies-literature
| S-EPMC7779630 | biostudies-literature
| S-EPMC7322422 | biostudies-literature